Stock Price & Analysis

The S1 support level for OSTX Stock is $1.85 ,The R1 resistant level for OSTX Stock is $3.24.

As of the end of day on 2025-02-05, the price of OSTX Stock was $1.93.

The target price for OSTX Stock according to analyst rating is 15.00, with the highest price target at 15.00 and the lowest at 15.00. Analysts have a Moderate Buy rating on OSTX Stock overall.

The market cap of OSTX is $41.0M.

OS Therapies Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. It built a pipeline of product candidates targeting multiple indications for solid cancers. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. OST-HER2 is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH sensitive silicone linkers (SiLinkers). The payloads can include antibodies, chemotherapeutics, cytotoxins and potentially mRNA treatments directly into and in the vicinity of solid tumors.

OSTX has a total of 4 employees.